Top 50 Biotechnology VC Funds & Investors in Australia (November 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Uniseed
VC Fund
|
29 | Australia, United States, United Kingdom | Series A, Seed, Series B | Biotechnology, Manufacturing, Health Care | $566k–$22M |
|
Brandon Capital
VC Fund
|
22 | Australia, United Kingdom, United States | Series A, Venture - Series Unknown, Seed | Biotechnology, Health Care, Medical | $914k–$81M |
|
Uniseed Ventures
VC Fund
|
19 | Australia, United States, United Kingdom | Series A, Seed, Series B | Biotechnology, Health Care, Manufacturing | $381k–$94M |
|
Artesian VC
VC Fund
|
17 | Australia, United States, China | Seed, Pre-Seed, Venture - Series Unknown | Software, Health Care, Artificial Intelligence | $29k–$17M |
|
Medical Research Commercialisation Fund (MRCF)
VC Fund
|
14 | Australia, United States, United Kingdom | Series A, Seed, Venture - Series Unknown | Biotechnology, Health Care, Medical | $1.3M–$35M |
|
Main Sequence Ventures
VC Fund
|
12 | Australia, United States, Philippines | Seed, Series A, Series B | Artificial Intelligence, Software, Information Technology | $1M–$72M |
|
Melbourne Angels
VC Fund
|
8 | Australia, New Zealand, United States | Seed, Angel | Software, Information Technology, Biotechnology | $44k–$1.5M |
|
Stoic VC
VC Fund
|
8 | Australia, United States, United Kingdom | Seed, Venture - Series Unknown, Series A | Biotechnology, Medical, Health Care | $600k–$24M |
|
Horizons Ventures
VC Fund
|
6 | United States, United Kingdom, Canada | Series A, Series B, Seed | Software, Artificial Intelligence, Biotechnology | $900k–$110M |
|
Brisbane Angels
VC Fund
|
6 | Australia, United States, New Zealand | Seed, Venture - Series Unknown, Pre-Seed | Software, Information Technology, Health Care | $120k–$2.8M |
|
Flying Fox Ventures
VC Fund
|
6 | Australia, New Zealand, United States | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Information Technology | $120k–$11M |
|
Sydney Angels
VC Fund
|
5 | Australia, United States | Seed, Angel, Pre-Seed | Software, SaaS, E-Commerce | $120k–$1.5M |
|
OneVentures
VC Fund
|
5 | Australia, United States, Israel | Series A, Debt Financing, Venture - Series Unknown | Software, Health Care, SaaS | $1.2M–$35M |
|
Yuuwa Capital
VC Fund
|
5 | Australia, France | Series A, Seed, Series B | Medical, Health Care, Biotechnology | $131k–$9.9M |
|
SOSV
VC Fund
|
5 | United States, China, Canada | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | $25k–$5M |
|
Australian Medical Angels
VC Fund
|
5 | Australia, Singapore, Hong Kong | Seed, Pre-Seed, Series A | Health Care, Medical, Software | $7.4k–$3.5M |
|
QIC BioVentures
VC Fund
|
4 | Australia | Series A, Venture - Series Unknown | Biotechnology, Health Care, Medical | |
|
Tin Alley Ventures
VC Fund
|
4 | Australia, Philippines, United States | Pre-Seed, Seed, Series B | Biotechnology, Life Science, Pharmaceutical | $430k–$20M |
|
Clean Energy Finance Corporation
VC Fund
|
4 | Australia, United Kingdom, United States | Debt Financing, Series B, Post-IPO Debt | Energy, Renewable Energy, Real Estate | $3.9M–$719M |
|
Development Bank of Wales
VC Fund
|
4 | United Kingdom, Australia, United States | Seed, Debt Financing, Venture - Series Unknown | Software, Manufacturing, Health Care | $19k–$5.9M |
|
Breakthrough Victoria
VC Fund
|
4 | Australia, United States, Philippines | Seed, Venture - Series Unknown, Series A | Health Care, Manufacturing, Biotechnology | $500k–$35M |
|
IP Group Australia
VC Fund
|
4 | Australia, New Zealand | Seed, Series A, Pre-Seed | Biotechnology, Manufacturing, Renewable Energy | $811k–$30M |
|
Possible Ventures
VC Fund
|
4 | Germany, United States, Australia | Seed, Pre-Seed, Series A | Software, Information Technology, Biotechnology | $586k–$47M |
|
Starfish Ventures
VC Fund
|
4 | Australia, United States, Philippines | Series A, Series B | Software, Enterprise Software, Internet | $2M–$18M |
|
GBS Ventures
VC Fund
|
3 | United States, Australia, United Kingdom | Series B, Series A | Biotechnology, Health Care, Medical Device | $2.2M–$35M |
|
Vectr
VC Fund
|
3 | United States, Hong Kong, Singapore | Seed, Series A, Series B | FinTech, Financial Services, Artificial Intelligence | $547k–$70M |
|
Grok Ventures
VC Fund
|
3 | Australia, United States, Singapore | Series A, Seed, Series B | Renewable Energy, Energy, Software | $941k–$151M |
|
Queensland Investment Corporation
VC Fund
|
3 | Australia, United States | Seed, Series A, Private Equity | Software, Information Technology, SaaS | $757k–$450M |
|
Tenmile
VC Fund
|
3 | Australia, United States, Canada | Venture - Series Unknown, Seed, Series A | Biotechnology, Health Care, Manufacturing | $2.5M–$177M |
|
Radar Ventures
VC Fund
|
3 | Australia, United States, New Zealand | Seed, Series A, Venture - Series Unknown | Biotechnology, Robotics, Health Care | $1.8M–$30M |
|
Tenacious Ventures
VC Fund
|
3 | Australia, United States, New Zealand | Seed, Pre-Seed, Series A | Agriculture, AgTech, Biotechnology | $896k–$49M |
|
South Australian Venture Capital Fund
VC Fund
|
3 | Australia | Seed, Series B, Series A | Health Care, Biotechnology, Internet of Things | $1M–$26M |
|
The George Institute for Global Health
VC Fund
|
2 | Australia | Seed | Biometrics, Health Care, Biotechnology | |
|
CP Ventures
VC Fund
|
2 | Australia, United States, India | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Machine Learning | $150k–$12M |
|
Maropost Ventures
VC Fund
|
2 | United States, Canada, Sweden | Series A, Seed | E-Commerce, Software, Internet | $1M–$160M |
|
ALIAVIA Ventures
VC Fund
|
2 | Australia, United States | Seed, Pre-Seed, Series A | Artificial Intelligence, Health Care, Information Technology | $200k–$5.6M |
|
Hitachi Ventures
VC Fund
|
2 | United States, United Kingdom, Australia | Series A, Series B, Seed | Software, Artificial Intelligence, Information Technology | $5M–$150M |
|
Hostplus
VC Fund
|
2 | Australia, United Kingdom, United States | Series A, Series B, Series C | Software, Biotechnology, Semiconductor | $6.3M–$111M |
|
Global Health Investment Fund (GHIF)
VC Fund
|
2 | United States, India, Austria | Series B, Series C, Venture - Series Unknown | Health Care, Biotechnology, Medical Device | $3.5M–$25M |
|
UniSA Ventures
VC Fund
|
2 | Australia | Seed, Pre-Seed | Software, Health Care, Biotechnology | |
|
BridgeLane Capital
VC Fund
|
2 | Australia, Germany, United States | Seed, Series A, Series B | Software, E-Commerce, Real Estate | $800k–$15M |
|
Canaan Partners
VC Fund
|
2 | United States, United Kingdom, Israel | Series A, Series B, Series C | Software, Biotechnology, Health Care | $5M–$80M |
|
Regal Funds Management
VC Fund
|
2 | Australia, United States, United Kingdom | Convertible Note, Series B, Venture - Series Unknown | Software, FinTech, Financial Services | $1.9M–$100M |
|
Victoria University of Wellington
VC Fund
|
2 | Australia, New Zealand | Pre-Seed, Seed | Health Care, Medical, Therapeutics | |
|
Empath Ventures
VC Fund
|
2 | United States, United Kingdom, Canada | Seed, Pre-Seed, Convertible Note | Health Care, Biotechnology, Personal Health | $1.6M–$12M |
|
Investible
VC Fund
|
2 | Australia, United States, Singapore | Seed, Series A, Pre-Seed | Software, Information Technology, Artificial Intelligence | $300k–$20M |
|
Catalio Capital Management
VC Fund
|
2 | United States, Israel, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $9.7M–$208M |
|
Closed Loop Partners
VC Fund
|
2 | United States, United Kingdom, Canada | Seed, Series A, Debt Financing | Recycling, Manufacturing, Waste Management | $2M–$16M |
|
Time Ventures
VC Fund
|
2 | United States, Germany, Australia | Series A, Series B, Seed | Software, Artificial Intelligence, Sustainability | $3.1M–$450M |
|
Thistledown Foundation
VC Fund
|
2 | Canada, Germany, Australia | Series A, Venture - Series Unknown, Seed | Energy, Environmental Engineering, Laser | $30M–$40M |
| Access all 376 VC funds in Australia Biotechnology startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Uniseed is Australia's first, and longest running, university owned venture fund. Established in 2000, we are owned by 9 universities plus CSIRO (behind over 60% of Australia's research) and fund deep-tech spinouts through to global scale.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Health Care
- Stage:Series A, Seed, Series B
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 94
- Round size: Seed $670k–$3.5M; Series A $1.6M–$16M; Series B $566k–$22M
- Lead/follow: 22% lead, 78% follow
- Last fund: May invest from a new fund soon — raised $15M in 2017
Portfolio highlights
- DeteQt — Semiconductor chip-based quantum magnetic field sensors using diamond - navigation, mining, medical imaging
- R2Crete — R2Crete is an engineering startup developing a process to recycle waste concrete into supplementary cementitious material (SCM) and high-quality aggregates for new concrete production. As cement is the most emissions-intensive component of concrete production, every tonne replaced by SCM directly reduces carbon impact. R2Crete's eco-friendly supplementary cementitious material (SCM) and aggregates are high performance, cost-competitive and can provide significant environmental benefits.
- Facet Amtech — Facet Amtech develops and produces ammonia from water and air.
Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Venture - Series Unknown, Seed
- Geography: Australia, United Kingdom, United States
Investor stats
- Total investments: 86
- Round size: Seed $914k–$9.7M; Series A $5.2M–$81M; Venture - Series Unknown $5.2M–$24M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely actively investing — fresh fund, raised $290M in 2025
Portfolio highlights
- Ena Respiratory — Ena Respiratory is a biotechnology company seeking to transform the treatment and prevention of respiratory infections and the effectiveness of vaccines.Ena Respiratory novel, synthetic Toll-like receptor 2 (TLR2) receptor agonists have been shown to activate the innate immune system in the respiratory tract and prevent viral and bacterialdissemination to the lungs.
- Lumonus — Lumonous is a healthcare company that offers Radiation Oncology, Radiation Therapy, and Cancer treatment technology-enabled services.
- OncoRes Medical — OncoRes Medical develops an imaging technology to provide intraoperative information available to surgeons to assist with the identification of tumor and healthy tissue.OncoRes Medical is an early-stage medical device company located in Perth, Western Australia and is developing the patent-protected technology in collaboration with leadingresearchers at the University of Western Australia and the Harry Perkins Institute of Medical Research and breast cancer surgeons at the Western Australian public health system.With funding provided by the Medical Research Commercialisation Fund (MRCF), OncoRes Medical aims to develop the technology for use in clinical applications that require the real-time assessment of tissue microstructure.
Uniseed is Australia's first, and longest running, university owned venture fund. Established in 2000, we are owned by 9 universities plus CSIRO (behind over 60% of Australia's research) and fund deep-tech spinouts through to global scale.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Series A, Seed, Series B
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 57
- Round size: Seed $381k–$4.6M; Series A $1.3M–$16M; Series B $471k–$94M
- Lead/follow: 12% lead, 88% follow
- Last fund: May invest from a new fund soon — raised $14M in 2017
Portfolio highlights
- BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Morse Micro — Morse Micro's Wi-Fi HaLow combines long-range, strong signal penetration, low power, and high throughput in one wireless protocol, delivering connectivity to more devices, at distance, with greater reliability.
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004, Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Australia, United States, China
Investor stats
- Total investments: 659
- Round size: Seed $40k–$4M; Pre-Seed $29k–$535k; Venture - Series Unknown $650k–$17M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely still investing — raised $36M in 2023
Portfolio highlights
- Vaulta — Vaulta is a battery casing technology company based in Brisbane, Australia. Using advanced composite materials and smart, streamlined design, Vaulta has developed a lighter and smaller battery case with fewer parts, creating scalable efficiencies and opportunities for manufacturers. Vaulta founder and director Dominic Spooner has over 12 yearsexperience as a design engineer, and has worked in a range of industries, including renewables and batteries, defence and aerospace, consumer products, commercial products and startups. While working in battery design, Dominic saw firsthand that opportunities for growth were being overlooked in favour of continuing with the status quo – and that’s when the idea for Vaulta was born.Vaulta’s world-first no-weld design means modules can be easily assembled and disassembled, cells reused and recycled, and new cells added as battery technology continues to evolve.From stationary storage and electric vehicles to defence, aerospace and beyond, Vaulta’s battery case technology works wherever batteries do.
- Coherence Neuro — Opto Biosystems specializes in the development of innovative healthcare technologies that bridge the gap between cancer neuroscience and bioelectronics. The company focuses on creating smaller, softer, and wireless biological interfaces designed to offer a new treatment modality. By leveraging advancements in neural engineering and bioelectronics,Opto Biosystems is dedicated to building new tools that interface with the body, aiming to improve patient outcomes in the healthcare sector. Their work includes exploring the stability of thin-film electrodes for neuromodulation, highlighting their commitment to advancing medical technology.
- Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 33
- Round size: Seed $1.3M–$1.7M; Series A $1.3M–$13M; Venture - Series Unknown $4.3M–$35M
- Lead/follow: 45% lead, 55% follow
Portfolio highlights
- MycRx — MecRx is a drug development company that works on new treatments for cancer and novel mechanism of action antibiotics. Using proprietary “hit identification” technology, MecRx is developing inhibitors of cMyc, a protein that is deregulated in over 50% of all human cancers. MecRx draws on the expertise of the Peter MacCallum Cancer Centre and CSIROand is headquartered in Melbourne, Australia.MecRx was founded in 2013 by an ex-pharma/biotech team. MecRx is run as a virtual company based in Melbourne, Australia and its shareholders and service providers include the Peter MacCallum Cancer Institute and CSIRO. The company secured $5m Series A investment from the MRCF (www.mrcf.com.au) and CSIRO in 2015.
- Currus Biologics — Currus Biologics develops BEAT technology to advance CAR T-cell therapy for solid tumors, aiming to improve treatment outcomes in oncology.
- Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
We work with inventors who are building something hard from their unique expertise in science. These inventors are building the industries that will thrive for the decades to come. We have a unique working model to accelerate a company's pathway to scale.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Seed, Series A, Series B
- Geography: Australia, United States, Philippines
Investor stats
- Total investments: 138
- Round size: Seed $1M–$7M; Series A $4.8M–$35M; Series B $14M–$72M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $305M in 2023
Portfolio highlights
- Diraq — Diraq is building quantum computers using modified silicon transistors, the technology best suited to reaching utility scale, where value outweighs cost.
- Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
- Gilmour Space Technologies — Gilmour Space is a rocket company in Australia that is developing and launching low-cost small satellite launch vehicles. All orbits, all planets: https://www.gspacetech.com
Melbourne Angels is the most active startup investor in Victoria, one of the most active in Australia. Investing in start-ups since 2007, Melbourne Angels is committed to helping innovative founders build the next generation of our economy.
Show more...Investment focus
- Industry: Software, Information Technology, Biotechnology
- Stage:Seed, Angel
- Geography: Australia, New Zealand, United States
Investor stats
- Total investments: 73
- Round size: Seed $44k–$1.5M; Angel $200k–$918k
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Emanda — Thinking about selling your business in Australia? Emanda guides you through every step: business valuation, health check, corporate compliance, and sale process. Start with a business valuation.
- Auric Essentials — Auric - The Power of Scent. Revolutionise your well-being with Auric. Discover our state-of-the-art AI-powered AromaSphere diffuser and app, designed to personalise your aromatherapy experience.
- Bitwise Agronomy — Bitwise Agronomy uses AI to analyze crop video footage and provide growers with insights into crop health, growth, and yield potential.
Stoic VC is an early-stage venture fund backing founders at the forefront of University Innovation. We partner with Uniseed to accelerate the commercialisation of university research across the ANZ.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 25
- Round size: Seed $600k–$4.6M; Series A $8.3M–$16M; Venture - Series Unknown $2.2M–$24M
- Lead/follow: 4% lead, 96% follow
- Last fund: May invest from a new fund soon — raised $11M in 2017
Portfolio highlights
- Ena Respiratory — Ena Respiratory is a biotechnology company seeking to transform the treatment and prevention of respiratory infections and the effectiveness of vaccines.Ena Respiratory novel, synthetic Toll-like receptor 2 (TLR2) receptor agonists have been shown to activate the innate immune system in the respiratory tract and prevent viral and bacterialdissemination to the lungs.
- Lenexa Medical — Lenexa Medical is an Australian based MedTech company.
- Kinoxis Therapeutics — Developing novel therapeutics for social dysfunction and substance use disorders.
Investing in the deep science and technology that can propel humanity towards a radically better future.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 357
- Round size: Seed $900k–$10M; Series A $4.8M–$42M; Series B $10M–$110M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- HZO — HZO delivers customized protective nano and conformal coatings that safeguard electronics from the most demanding environments. It provides water protection solutions for electronics manufacturers by introducing a durable film to components during assembly. The company specializes in the fields of nanotechnology, waterproofing, electronics,nano-coating, full-submersion.It was founded in 2011 and headquartered in Morrisville, North Carolina.
- FiSee AI — FiSee AI is an academic vertical AI search service provider.
- Atomo Coffee — Atomo Coffee is a developer of molecular coffee. Atomo has reverse-engineered the coffee bean to create a smooth cup of coffee, made of naturally derived ingredients, and more sustainable than current commercial coffee.
Formed in late 2006, the Brisbane Angels Pty Ltd is a large group of private investors who actively invest in early stage technology companies, usually in South East Queensland, Australia. The members are typically active or semi-retired former senior business executives, who apart from financial input can provide much needed value adding to investee companies through hands-on management experience and high level business networks.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: Australia, United States, New Zealand
Investor stats
- Total investments: 112
- Round size: Seed $120k–$2.1M; Pre-Seed $200k–$1.4M; Venture - Series Unknown $543k–$2.8M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Indi — indi keeps every observation, document and reminder about your child organised in one place, ready to share with the clinicians and family supporting them.
- Ovum — Meet Ovum, the intelligent health journal mobile app designed for womankind.
- Aussie colours —
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Flying Fox Ventures is an early stage investment firm that invests across industry and across the micro-stages of pre-seed and seed.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, New Zealand, United States
Investor stats
- Total investments: 112
- Round size: Seed $662k–$3.2M; Pre-Seed $120k–$3M; Series A $649k–$11M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Operata — Continuously measure performance to deliver the best possible customer experience.
- SPEC Toolbox — Design CLT, glulam and connection details to AS1720.1 in minutes, with certified AU/NZ supplier data built into every SPEC Toolbox calculator.
- Teacher’s Buddy — Create lesson plans, worksheets, assessments, and more in minutes. AI-powered tools designed for educators.
Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companies They believe that encouraging smart investment in startup companies will benefit both our members’ portfolios and Australia’s emergent innovation economy. They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.
Show more...Investment focus
- Industry: Software, SaaS, E-Commerce
- Stage:Seed, Angel, Pre-Seed
- Geography: Australia, United States
Investor stats
- Total investments: 99
- Round size: Seed $120k–$1.5M; Angel $130k–$1.1M; Pre-Seed $357k–$1.5M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — last raise in 2016
Portfolio highlights
- Keeyu — keeyu. is a B2B SaaS platform that continuously monitors e-commerce transactions from payment to delivery. Should any issue emerge, our system immediately notifies the customer service team, enabling proactive issue resolution before it impacts the customer, saving them from opening a support ticket. The result is an enhanced post-purchaseexperience, ensuring sales retention and reducing customer complaints.Founded in 2023, the company is headquartered in Sydney, Australia, and is dedicated to empowering businesses to deliver exceptional post-purchase experiences.
- iiShield — iiShield aims to improve patient outcomes and surgeon training in transplant surgery by providing effective organ heat protection.
- Mary Technology — Generate detailed chronologies from documents in minutes with Mary Technology. Achieve 90%+ time reduction and ensure 99%+ accuracy. Try for free.
OneVentures is a later-stage venture capital firm focused on scaling Technology and Healthcare companies through growth equity and credit. The firm's role extends far beyond investment, as the firm actively guides companies toward achieving their next critical milestones. By leveraging decades of global experience and operational expertise, OneVentures accelerates growth and helps shape the future of its portfolio companies. A global growth focus drives their investment selection, with their current portfolio including companies with truly innovative products tackling multi-billion-dollar problems, from needle-free vaccinations to virtual communications to adaptive e-learning.
Show more...Investment focus
- Industry: Software, Health Care, SaaS
- Stage:Series A, Debt Financing, Venture - Series Unknown
- Geography: Australia, United States, Israel
Investor stats
- Total investments: 88
- Round size: Series A $1.5M–$23M; Debt Financing $1.2M–$14M; Venture - Series Unknown $3M–$35M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely actively investing — fresh fund, raised $126M in 2025
Portfolio highlights
- me&u — me&u is an online ordering and payment application designed to order meals. They provide communication technology to order and pay through mobile phones at restaurants. Their process of ordering with waiters and splitting bills that enable users to order their food and pay bills through a digital payment platform.
- Truescope — Make better informed communications decisions with Truescope. Harnessing millions of media posts every day to deliver you real-time information that influences your business strategy.
- Vertero — Axial Therapeutics is a biotechnology company fundamentally changing the treatment of neurological diseases and disorders by harnessing groundbreaking science in the microbiome-gut-brain axis.
Yuuwa Capital is a $40M early-stage venture capital firm based in Perth, Western Australia. They are actively seeking outstanding investment opportunities where Yuuwa can provide both capital and expertise to help founders, management and early investors to turn good ideas into great companies.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: Australia, France
Investor stats
- Total investments: 22
- Round size: Seed $131k–$808k; Series A $979k–$4.2M; Series B $2.6M–$9.9M
- Lead/follow: 59% lead, 41% follow
- Last fund: May invest from a new fund soon — raised $37M in 2009
Portfolio highlights
- Nexgen Plants — Healthy plants, healthy people, living planet. Nexgen develop's plants for future generations that will improve the environment and health of future generations.
- Icetana — icetana Motion Intelligence dramatically improves the active monitoring of security surveillance networks, with AI video anomaly detection and video analytics.
- Agworld — Plan your crop, mitigate your risks, improve your profitability with Agworld farm management software.
SOSV offers pre-seed capital and follow-on financial support to startups focusing on deep technology and scientific innovation. Founders utilize purpose-built laboratory facilities and engineering spaces to accelerate product development and testing. The firm facilitates connections between entrepreneurs and a network of investors through structured matchmaking events and technology summits.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, China, Canada
Investor stats
- Total investments: 3821
- Round size: Seed $125k–$5M; Pre-Seed $25k–$1.5M; Convertible Note $50k–$3.6M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely still investing — raised $306M in 2023
Portfolio highlights
- Halla — Halla Intelligence is a digital solution that leverages over 100 billion shopper and product data points to recommend and promote what grocery items.
- Verdex Technologies — Verdex Technologies is an advanced materials platform technology that uses nanofibers to disrupt industries. Verdex doesn't just compete, it innovates and disrupts.
- Samphire Neuroscience — Samphire Neuroscience builds clinically validated neurotechnology to support women across their lives. Our wearable devices, Nettle™ and Lutea™, are built on the same underlying brain-stimulation technology, targeting neural pathways involved in pain, mood, stress, and sleep regulation. - Lutea™ is available globally as a wellness device. Itstimulates the same regions of the brain to support stress regulation, sleep, and recovery - key drivers of readiness and long-term performance - allowing athletes and teams to move beyond wellbeing education alone to practical, evidence-based intervention. - Nettle™ is a CE-marked (EU and UK regulated), drug- and hormone-free device that has been clinically shown to improve pain, mood, functionality, and the ability to train during the menstrual cycle, with measurable benefits after one month of use - supporting athletes to maintain training intensity and movement quality during their period. - The Samphire App is the platform controlling all Samphire hardware products with the use of CycleSync™ AI technology: the only one of its kind to support personalized neurotechnology use for women.
Medical Angels is the premier medical and health-specific angel investment syndicate, comprised of over 1,000 clinicians from across Australia. In 2026, we
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Australia, Singapore, Hong Kong
Investor stats
- Total investments: 22
- Round size: Seed $7.4k–$1.7M; Pre-Seed $550k–$1M; Series A $3.3M–$3.5M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- GXE — At GXE, our mission is to build the all-in-one platform for unlisted assets and funds management. We provide investors, fund managers, and family offices with the tools they need to succeed and enable them to focus on their portfolios and investors whilst GXE takes care of everything else. A licensed financial services company, GXE holdsAustralian Financial Services Licence 460870 issued by the Australian Securities and Investments Commission. GXE welcomes clients across sectors including corporate, family offices, pension and superannuation fund managers, private equity, property, and venture capital.
- Graphics et al. — Graphics et al. is a software that offers to create graphic designs. Graphics et al. mission is to make scientific communication easier.
- Clean Slate Clinic — Safely detox from alcohol from the comfort of your home. Proven results with Clean Slate Clinic.
QIC BioVentures is a venture capital for biotechnology firm.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Venture - Series Unknown
- Geography: Australia
Investor stats
- Total investments: 4
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Hatchtech — Hatchtech is an Australian company developing a locally developed proprietary technology platform that will enable the creation of a new generation of lowtoxicity pest control products. Specifically, the patented technology allows the complete blocking of pest species egg hatch through a novel mode of action. The technology has applicability forcontrolling ectoparasites and other egg laying pests of humans, animal, crops and the built environment.
- Verva Pharmaceuticals — Verva Pharmaceuticals Ltd. (“Verva”) was formed in December, 2007 by consolidation of key diabetes assets, discovery technologies and targets resident in Autogen Research Ltd. (formerly the diabetes-focused subsidiary of ChemGenex Pharmaceuticals) with those of obesity drug development company Adipogen Pharmaceuticals Pty Ltd. The combined productportfolio, technologies and expertise provide a substantial opportunity for rapid clinical progress and growth in high-value markets with a significant unmet medical need.Verva operates in a completely virtual mode, managed by a CEO and Directors with extensive international product development and partnering experience. Verva’s founding research was undertaken at the Metabolic Research Unit of Deakin University in Geelong, Australia; a state-of-the-art facility providing access to key in vitro and in vivo models and capabilities. Verva has subsequently engaged expert scientists, clinicians, technical advisers and contract research organisations worldwide to implement the Company’s research and development strategy.
- Protagonist Therapeutics — Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical needs.
Our primary focus is on spinouts built upon research intellectual property, however we can also invest in existing companies if the link to the University of Melbourne is strong. We lead rounds and can invest from A$500,000 up to A$5m.
Show more...Investment focus
- Industry: Biotechnology, Life Science, Pharmaceutical
- Stage:Pre-Seed, Seed, Series B
- Geography: Australia, Philippines, United States
Investor stats
- Total investments: 9
- Round size: Seed $2.9M–$20M; Pre-Seed $430k–$2.9M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Twin1 AI — Twin1 is a privacy-first platform that gives every professional an AI-powered digital twin to scale their expertise.
- Skopos Bio — Skopos Bio is an Australian biotechnology company developing targeted radiopharmaceutical therapies for cancer treatment.
- Kronus — Kronus compiles engineering intent into software, tests, and assurance evidence; traceably and deterministically.
The Clean Energy Finance Corporation invests using a commercial approach to overcome market barriers and mobilize investment in renewable energy, energy efficiency, and low emissions technologies. They seek to catalyze and leverage private sector funding for the commercialization and deployment of clean energy technologies necessary for the transition to a carbon-constrained economy.
Show more...Investment focus
- Industry: Energy, Renewable Energy, Real Estate
- Stage:Debt Financing, Series B, Post-IPO Debt
- Geography: Australia, United Kingdom, United States
Investor stats
- Total investments: 156
- Round size: Series B $3.9M–$77M; Post-IPO Debt $41M–$719M; Debt Financing $12M–$329M
- Lead/follow: 42% lead, 58% follow
- Last fund: May invest from a new fund soon — raised $72M in 2018
Portfolio highlights
- Zenobe Energy — Zenobe Energy ( formerly known as Battery Energy Storage Solutions Limited) is the largest independent owner and operator of battery storage in the UK. We transform the way grid operators and businesses use power to reduce costs, improve reliability and benefit the environment.
- Renewable Metals — Renewable Metals' unique alkali recycling process recovers critical minerals from old batteries so they can be used again and again.
- Agile Energy — Empowering Australian businesses with solar, power purchase agreement, batteries, carbon offsets & renewable energy. Save costs, cut emissions, and start your sustainability journey today!
Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.
Show more...Investment focus
- Industry: Software, Manufacturing, Health Care
- Stage:Seed, Debt Financing, Venture - Series Unknown
- Geography: United Kingdom, Australia, United States
Investor stats
- Total investments: 301
- Round size: Seed $327k–$2.5M; Debt Financing $19k–$3.7M; Venture - Series Unknown $383k–$5.9M
- Lead/follow: 61% lead, 39% follow
- Last fund: May invest from a new fund soon — raised $27M in 2018
Portfolio highlights
- Design and Supply — Design and Supply provides products and services primarily for the construction industry, offering Jansen-certified products and British SBD solutions. The company manufactures and supplies items, including steel doors. Additionally, Design and Supply caters to design enthusiasts by offering artwork, fine furniture, antiques, and decor.
- MeOmics Technology — MeOmics Technology is a biotech company with a focus on improving the diagnosis and treatment of mental health illnesses. The company operates in the manufacturing industry and has a team of 9 employees. The team includes experts in Neuronal Cell Biology and Neuropsychopharmacology. The company's mission is to leverage technology to enhancethe understanding and treatment of mental health conditions.
- Outlook Expeditions — Outlook Expeditions provide overseas educational expeditions, adventure travel and service-learning projects for schools.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!The Breakthrough Victoria Fund is a $2 billion investment by the Victorian Government to drive investment in research and innovation.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Biotechnology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Australia, United States, Philippines
Investor stats
- Total investments: 55
- Round size: Seed $708k–$6.8M; Series A $4M–$35M; Venture - Series Unknown $500k–$30M
- Lead/follow: 53% lead, 47% follow
Portfolio highlights
- AlleSense — AlleSense has developed a unique and novel solution to label-free imaging, the NanoMslide.
- Mental Jam — We are a games studio dedicated to creating impactful experiences that explore mental health.
- Deftbiotech — Deftbiotech is a biotech startup developing peptide-based antifungal treatments for nail and skin infections.
Ip Group Australia build and support outstanding intellectual property-based companies.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Renewable Energy
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, New Zealand
Investor stats
- Total investments: 15
- Round size: Seed $1.3M–$2.3M; Pre-Seed $811k–$896k; Series A $3M–$30M
- Lead/follow: 47% lead, 53% follow
Portfolio highlights
- ElectraLith — The cleanest, most versatile and most cost-efficient method of extracting and refining lithium, the primary element of a sustainable future.
- MGA Thermal — MGA Thermal, specialists in thermal energy storage technology. Renewable, high-power, economical, modular, safe and sustainable thermal storage solutions.
- Atisama Therapeutics — Atisama Therapeutics is an Australian biotech company pioneering splice-switching oligonucleotide (SSO) therapies that restore normal gene transcription pathways to treat disease at the molecular level.
Possible Ventures backs ambitious teams building frontier technology to positively impact society. We invest globally in the early stages, actively supporting founders via our collective of global entrepreneurs.
Show more...Investment focus
- Industry: Software, Information Technology, Biotechnology
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, United States, Australia
Investor stats
- Total investments: 174
- Round size: Seed $1.5M–$10M; Pre-Seed $586k–$3.5M; Series A $9.7M–$47M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Mkind — Mkind builds intelligent robots for high-mix manufacturing, developing advanced automation solutions that can adapt to diverse production requirements, improve operational efficiency, and support manufacturers in handling complex, low-volume, and frequently changing product lines.
- Reverion — Reverion develops reversible and carbon-negative power plants using patented biogas technology for renewable energy.
- Coherence Neuro — Opto Biosystems specializes in the development of innovative healthcare technologies that bridge the gap between cancer neuroscience and bioelectronics. The company focuses on creating smaller, softer, and wireless biological interfaces designed to offer a new treatment modality. By leveraging advancements in neural engineering and bioelectronics,Opto Biosystems is dedicated to building new tools that interface with the body, aiming to improve patient outcomes in the healthcare sector. Their work includes exploring the stability of thin-film electrodes for neuromodulation, highlighting their commitment to advancing medical technology.
Starfish Ventures is a venture capital firm. That specializes in seed, start-up, expansion, emerging growth, early venture, mid venture, late venture, growth capital, middle market, and buyouts investments. The company prefers to invests in life sciences, clean technology, materials science, and information technology. Within life sciences, it focuses on biotechnology, medical devices, therapeutics, and drug development. Within clean technology, the firm invests in energy, water, and other environmental technologies. Within information technology, it considers investments in software, mobile, Internet and cloud based enterprise systems, semiconductor, instrumentation, hardware, and telecommunications. It seeks to exit its investments through mergers and acquisitions, trade sale, or an initial public offer within two to five years. Starfish Ventures was founded by John Dyson and Michael Panaccio in 2001, and is headquartered in Melbourne, Australia.
Show more...Investment focus
- Industry: Software, Enterprise Software, Internet
- Stage:Series A, Series B
- Geography: Australia, United States, Philippines
Investor stats
- Total investments: 62
- Round size: Series A $2M–$6.6M; Series B $3.8M–$18M
- Lead/follow: 48% lead, 52% follow
- Last fund: May invest from a new fund soon — raised $162M in 2008
Portfolio highlights
- CAP-XX — CAP-XX makes ultra-thin, high-power supercapacitors for portable and compact devices. Ideal for energy storage. Quotes & samples available.
- Ourcast — Ourcast Inc. has a mobile app that it says can accurately predict precipitation during the next two hours.
- Smart Urban Properties Australia (SUPA) — Smart Urban Properties Australia (SUPA) offers a unique range of property solutions by bringing together renewable energy and mobility, super-speed fiber, and smart prop-tech. It is formed by bringing together Epsilon Security, b.energy, Fibrecorp, Smart Automation Systems, and connecX.
Founded in 1996, GBS invests in young businesses developing and commercialising products which, when combined with the right management and finance, will make a significant difference to patients' lives and deliver financial returns for their investors. Their areas of particular interest and expertise include human healthcare, biotechnology product development and life science start-ups. In particular, recent investments have included biological or small molecule therapeutics, medical devices and diagnostics. GBS invests in private or public companies whether at start-up or later stages of company development. Their investors include major Australian superannuation funds.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical Device
- Stage:Series B, Series A
- Geography: United States, Australia, United Kingdom
Investor stats
- Total investments: 42
- Round size: Series A $2.2M–$9M; Series B $9.1M–$35M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — raised $86M in 2009
Portfolio highlights
- Ivantis — Ivantis, Inc. is a company focused on developing an innovative treatment for Glaucoma. It is their goal to develop a less invasive, more effective option for the 60+ million people worldwide suffering from Primary Open Angle Glaucoma. As they successfully address this initial goal, it is then there intention to focus on innovative development forthe treatment of other debilitating diseases within ophthalmology.
- Moximed — Moximed Inc. is dedicated to improving the standard of care for patients with osteoarthritis, and is investigating therapies to treat a number of affected joints. The lead product, the KineSpring® Knee Implant System, is designed for patients with knee osteoarthritis.
- Elastagen — Elastagen is a clinical stage medical company with an advanced pipeline of products based on the human protein tropoelastin, a pioneering medical biomaterial. Elastin is a critical component of tissues in the human body which require the ability to stretch and recoil, such as the skin, lungs, arteries, elastic ligaments. Elastagen hasdeveloped a synthetic version of the elastin protein which is identical to that naturally present in the human body. Elastagen’s platform technology has potential applications in a number of areas including skin rejuvenation, scar remodelling and tissue repair. Elastagen was founded following the acquisition of intellectual property rights to the elastin technology which was developed by Prof Weiss at the University of Sydney. The Company has since successfully attracted capital from a number of leading Australian and overseas life science venture capital groups. Elastagen’s operations have expanded from its Australian base to include production in Europe and clinical operations in the UK.
Vectr is a venture firm based in Hong Kong. They combine investment, creation and growth to deliver game-changing impact to teams ready to tackle global issues, transform industries and improve the lives of millions.That combines capital, creation and partnership to deliver game-changing impact. We strive to be the ideal partner for founders that are building transformation products and looking to expand their businesses into asia.
Show more...Investment focus
- Industry: FinTech, Financial Services, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, Hong Kong, Singapore
Investor stats
- Total investments: 81
- Round size: Seed $547k–$6.5M; Series A $1M–$37M; Series B $12M–$70M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Airstack — Every day there are millions of blockchain transactions. Airstack makes sense of them.
- Micro Connect — Micro Connect provides market infrastructure, fintech, and platform development.
- MasterExchange — Trading platform for music rights leveraging emerging technology to create friction free and compliant investment opportunities to everyone.
Backing a better tomorrow
Show more...Investment focus
- Industry: Renewable Energy, Energy, Software
- Stage:Series A, Seed, Series B
- Geography: Australia, United States, Singapore
Investor stats
- Total investments: 70
- Round size: Seed $941k–$10M; Series A $3.5M–$63M; Series B $26M–$151M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- Endolith — Endolith is a biotech company transforming sustainable mining by leveraging microbes, synthetic biology, and cloud computing to extract more critical minerals like copper from low-grade ores. Working with the many of the leading mining companies, Endolith is advancing its innovative technology to commercial scale. Recognized as a finalist in theBHP Unearthed BioMetals cohort and a member of the Alaska Critical Minerals Collaborative, Endolith is driving the future of mining with sustainable, efficient, and responsible solutions for the clean energy transition.
- MAKO — Solving human problems with nature’s surfaces.
- Asterix Foods — Asterix Foods is a biotechnology company designed to build protein production using plant-cell culture techniques. The company's platform is developing and growing bioactive proteins for food that are scalable, functional, and complex, enabling users with plant cell-cultured and animal-free proteins.It was founded in 2022 and is located inTel Aviv, Israel.
Queensland Investment Corporation is an investment company.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Series A, Private Equity
- Geography: Australia, United States
Investor stats
- Total investments: 29
- Round size: Seed $757k–$10M; Series A $3.6M–$10M; Private Equity $239M–$450M
- Lead/follow: 45% lead, 55% follow
- Last fund: Likely still investing — raised $15M in 2022
Portfolio highlights
- ModnPods — B2B modular manufacturing for multi-storey & hybrid developments across QLD & NSW. Backed by McNab. Accelerate builds by 50%.
- Pacific Energy — Our innovative energy solutions are transforming the way power is generated, delivered, and managed across the nation.
- Gilmour Space Technologies — Gilmour Space is a rocket company in Australia that is developing and launching low-cost small satellite launch vehicles. All orbits, all planets: https://www.gspacetech.com
Tenmile invest quickly and confidently because it lacks the constraints that most venture capital funds.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: Australia, United States, Canada
Investor stats
- Total investments: 22
- Round size: Seed $2.5M–$8.3M; Series A $3M–$177M; Venture - Series Unknown $7.5M–$90M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- Kantoko — Kantoko is a dedicated Australian mental health platform that provides online ADHD assessment, diagnosis, and long-term care for adults.
- AdvanCell — AdvanCell is a vertically integrated, clinical-stage radiopharmaceutical company developing an innovative pipeline of targeted alpha therapies.
- Skopos Bio — Skopos Bio is an Australian biotechnology company developing targeted radiopharmaceutical therapies for cancer treatment.
Radar Ventures operates as an venture capital firm.
Show more...Investment focus
- Industry: Biotechnology, Robotics, Health Care
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Australia, United States, New Zealand
Investor stats
- Total investments: 22
- Round size: Seed $1.8M–$11M; Series A $3.2M–$15M; Venture - Series Unknown $19M–$30M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Acumino — AI-powered robot models for dexterous industrial automation.
- OncoRes Medical — OncoRes Medical develops an imaging technology to provide intraoperative information available to surgeons to assist with the identification of tumor and healthy tissue.OncoRes Medical is an early-stage medical device company located in Perth, Western Australia and is developing the patent-protected technology in collaboration with leadingresearchers at the University of Western Australia and the Harry Perkins Institute of Medical Research and breast cancer surgeons at the Western Australian public health system.With funding provided by the Medical Research Commercialisation Fund (MRCF), OncoRes Medical aims to develop the technology for use in clinical applications that require the real-time assessment of tissue microstructure.
- Diag-Nose.io — Antibiotic resistance is rising to dangerously high levels in all parts of the world threatening our ability to treat common infectious diseases. Diag-Nose is working on a novel diagnostic tool to non-invasively distinguish between viral,bacterial and allergy-mediated sinusitis.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Tenacious Ventures - Australia's first and only dedicated agrifood tech VC firm.
Show more...Investment focus
- Industry: Agriculture, AgTech, Biotechnology
- Stage:Seed, Pre-Seed, Series A
- Geography: Australia, United States, New Zealand
Investor stats
- Total investments: 24
- Round size: Seed $1.1M–$10M; Pre-Seed $896k–$2.2M; Series A $5.9M–$49M
- Lead/follow: 50% lead, 50% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Nbryo — Transforming beef & dairy production systems with advanced genetic breeding technology and solutions. Learn how Nbryo can optimise the entire value chain.
- Agovor — Agovor - Robotic towing machines to boost productivity while reducing your environmental footprint.
- SwarmFarm Robotics — Global crop protection specialists ADAMA and Australian ag-tech company.
South Australian Venture Capital Fund - helping build dynamic and innovative South Australian startups / scaleups and accelerate their growth to a national and global scale.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Internet of Things
- Stage:Seed, Series B, Series A
- Geography: Australia
Investor stats
- Total investments: 14
- Round size: Seed $1M–$12M; Series A $2.3M–$20M; Series B $13M–$26M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Seonix Bio — Seonix Bio aims to improve the treatment and prevention of blinding eye disease by developing advanced risk prediction tools.
- Pearler.AI — Pearler gives your team super powers to respond fast to RFP, RFI, RFQ, Security, Cyber, Risk & Grant Questionnaires.
The George Institute is on a mission to improve the health of millions of people worldwide. Join us in our fight for a healthier world.
Show more...Investment focus
- Industry: Biometrics, Health Care, Biotechnology
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CellSync — CellSync is a Biotechnology Research firm that is working to make changes in the Future of Cell Engineering.
- Sineva — Sineva is a medical device manufacturing firm that makes ultrasonography simulators.
- Neogenix Biosciences — NeoGenix Fertility: Selecting sperm for life through microfluidics and AI
Two top decile funds, both fully deployed. Pre-seed and seed technology companies, backed again as they grow. Sydney, since 2018.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Seed, Pre-Seed, Series A
- Geography: Australia, United States, India
Investor stats
- Total investments: 92
- Round size: Seed $482k–$4.2M; Pre-Seed $150k–$900k; Series A $3.8M–$12M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- RedOwl AI — RedOwl leverages the power of generative AI to empower of the office of the CFO to make error-free and compliant pre-transactional decisioning.
- LeadStory — Watch breaking news video from providers you can trust. Follow the topics you care about and see whats happening near you or anywhere in the world.
- Greenfly — Greenfly is an enterprise SaaS company and the leader in advocacy marketing. The Greenfly digital media exchange platform enables organizations to fuel brand love by tapping the social media power of their advocates. Emotional connection is the key to building a brand that people love. You can’t buy it – brand love is earned through genuineinteractions, personal connections and real word-of-mouth. Sports, media, entertainment, social causes, and agent-driven organizations depend on Greenfly’s advocacy marketing platform to easily share short-form media. When advocates share great photos and videos on their social profiles, it creates personal engagement with the brand’s customers. Organizations can extend their organic social media reach by 1,000% or more, and brand advocacy can be more effective and much less expensive than social advertising.Greenfly started helping sports and entertainment brands in 2014, and has been named one of the fastest-growing organizations in California by Inc. magazine. Headquartered in Santa Monica, California, Greenfly has sales offices across the U.S. and Europe.
Maropost Ventures is a leading private equity firm that invests in people and their companies from the earliest days through all stages of Growth. SpaceX, Compono, Pressa and Lyres make up some of their first investments.
Show more...Investment focus
- Industry: E-Commerce, Software, Internet
- Stage:Series A, Seed
- Geography: United States, Canada, Sweden
Investor stats
- Total investments: 55
- Round size: Seed $1M–$11M; Series A $8.5M–$160M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Apteo — Use your customer data to drive more sales by hyper-targeting and personalizing your marketing campaigns.
- Arro — Start building credit with Arro. Get instant virtual card access, earn 1% cash back, and grow your limit by learning and paying on time, no hard credit check.
- Intelligems — IntelliGems is Online stores are leaving money on the table by pricing inefficiently. We run A/B tests to find the optimal price to maximize sales and margin.
Investing early in female-founded AI companies across the U.S. and Australia.
Show more...Investment focus
- Industry: Artificial Intelligence, Health Care, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: Australia, United States
Investor stats
- Total investments: 15
- Round size: Seed $750k–$5.6M; Pre-Seed $200k–$1.3M; Series A $649k–$1.7M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- Human Health — Human aims to assist medical professionals and patients to make more statistics selections.
- InsightWise — Win more proposals and grants, and drive growth faster than ever with AI-powered drafting.
- GoFIGR — We are a talent insights and opportunity marketplace platform that helps you develop, engage and retain employees in the flow of work.
Official website of Hitachi, Ltd. Hitachi drives Social Innovation Business, creating a sustainable society with data and technology. We will solve customers' and society's challenges with Lumada solutions leveraging IT, OT (Operational Technology) and products.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Australia
Investor stats
- Total investments: 78
- Round size: Seed $5M–$23M; Series A $10M–$50M; Series B $21M–$150M
- Lead/follow: 21% lead, 79% follow
- Last fund: Likely actively investing — fresh fund, raised $400M in 2025
Portfolio highlights
- Arcee AI — Learn how Arcee helps you build your own LLMs in your own cloud.
- RapidCanvas — Delivering industry benchmarked out-of-the-box AI solutions that can be easily customized by business users using conversational interface.
- ClearOps — ClearOps is the AI-powered After Sales Platform connecting machinery OEMs, dealers and machines to improve spare parts availability, fill rates and machine uptime.
Join our leading Australian superannuation fund, committed to putting our members first, with a low admin fee and strong returns. Become a member today!
Show more...Investment focus
- Industry: Software, Biotechnology, Semiconductor
- Stage:Series A, Series B, Series C
- Geography: Australia, United Kingdom, United States
Investor stats
- Total investments: 64
- Round size: Series A $6.3M–$84M; Series B $20M–$111M; Series C $13M–$60M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Emesent — Solutions for GPS-denied environments - delivering revolutionary efficiency, safety and operational insights to underground mining and other industries.
- Universal Quantum — Universal Quantum is building quantum computers to tackle real-world problems that would take today’s fastest supercomputers billions of years to solve.
- Gilmour Space Technologies — Gilmour Space is a rocket company in Australia that is developing and launching low-cost small satellite launch vehicles. All orbits, all planets: https://www.gspacetech.com
The Global Health Investment Fund (GHIF) is a $108 million social impact investment fund designed to provide financing to advance the development of drugs, vaccines, diagnostics and other interventions against diseases that disproportionately burden low- and middle-income countries. GHIF supports late-stage innovations for public health challenges such as malaria, pre-eclampsia, cholera, HIV and river blindness, with an emphasis on infectious diseases and maternal/infant health issues that cause significant morbidity and mortality in resource-limited settings. GHIF may also make investments that improve or expand access to existing products—such as developing pediatric formulations of approved therapeutics or improving the stability of widely-used global health vaccines. As an investment fund with a limited time-horizon, GHIF seeks opportunities that have a high probability of successful commercialization within two or three years. Products with “dual market” potential are of greatest interest; i.e., those that will have a clear impact on public health in developing countries but also have value in high-income countries. High-volume / low-margin products, such as essential vaccines, are also of significant interest. GHIF employs a range of investment structures including mezzanine debt, convertible debt, preferred equity and project financing with an average investment target of approximately $10 million per project. Each GHIF project must advance the Fund’s social impact objectives and demonstrate the ability to achieve commercial success.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series B, Series C, Venture - Series Unknown
- Geography: United States, India, Austria
Investor stats
- Total investments: 21
- Round size: Series B $7.5M–$19M; Series C $4.5M–$14M; Venture - Series Unknown $3.5M–$25M
- Lead/follow: 43% lead, 57% follow
- Last fund: May invest from a new fund soon — raised $108M in 2012
Portfolio highlights
- Monod Bio — Monod Bio l Simple. Powerful. Biosensors for Medicine & Biotech.
- CXL Ophthalmics — CXLO is developing a minimally invasive treatment for an ectatic corneal disease that can bring early intervention to millions of patients globally.
- Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.
UniSA Ventures is the technology commercialisation and investment management company of the University of South Australia (UniSA).
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Pre-Seed
- Geography: Australia
Investor stats
- Total investments: 3
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $31M in 2019
Portfolio highlights
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Framework — Framework is an all-in-one tool for teams and individuals. You can use Framework to do anything from project management, sales pipeline & customer relationship management, wiki & documentation, team communication (team chat, voice & video calls), and meeting scheduling.Framework can help organize your ideas with nodes. A node is apiece of information and each node is connected and related to other nodes.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!The BridgeLane Group is a privately-owned asset management firm specialising in the agricultural, real estate and innovation sectors. A significant global player in agriculture with a multi-decade record in large scale farming, the Group has a proud history in residential property development, comme
Show more...Investment focus
- Industry: Software, E-Commerce, Real Estate
- Stage:Seed, Series A, Series B
- Geography: Australia, Germany, United States
Investor stats
- Total investments: 20
- Round size: Seed $800k–$4.6M; Series A $3M–$6.1M; Series B $5M–$15M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- MadeComfy — Award-winning Airbnb management service in Australia and New Zealand. MadeComfy is a selected official partner of Airbnb. Find out how we earn you higher returns with short-term rentals.
- Futurerent — With Futurerent, property investors can get up to $100,000 in a seamless, loan-free experience that's so simple, banks can only dream of it.
- Evrima Technologies — Our clinical trial recruitment and management services put participants first. Trusted, timely clinical trial results are a good thing - for everybody.
Canaan is an early stage venture capital firm that invests in entrepreneurs with visionary ideas. With $5B under management, a diversified fund and over 190 exits to date, Canaan has invested in some of the world's leading technology and healthcare companies over the past 30 years. Canaan’s focus areas include fintech, enterprise/cloud,marketplaces, frontier tech, biopharma, digital health, and medtech.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 705
- Round size: Series A $5M–$42M; Series B $8M–$80M; Series C $7.1M–$55M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — raised $100M in 2024
Portfolio highlights
- withco — Rebuilding main street, one share at a time.
- Hermeus — Hermeus is developing hypersonic aircraft to connect the world faster than ever before.
- GroundWork — GroundWork delivers Unified Monitoring for Real™ with an open software platform for shockingly easy integrations and customized visualizations of cloud, virtualization, network, application, server, and storage data.GroundWork Monitor is available in free (Core) and subscription versions with support (Enterprise).GroundWork was founded in 2004 andis headquartered in San Francisco, California with partners in Asia Pacific, Europe and South America.
Regal Funds Management was founded in 2004 by Andrew and Philip King. Regal utilises a long/short investment strategy and performs investment management and investment advisory services to a number of Australian Unit Trusts and Cayman Island Companies.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Convertible Note, Series B, Venture - Series Unknown
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 85
- Round size: Series B $7M–$30M; Convertible Note $1.9M–$18M; Venture - Series Unknown $4M–$100M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — raised $52M in 2022
Portfolio highlights
- Send Payments — SendFX provides cross-border payment and remittance services to individuals and SMEs.
- Firmus Technologies — Firmus Technologies creates the most efficient AI infrastructure: AI Factories designed to operate at the max-q of AI token generation and profitability. With advanced liquid-everywhere data center technology at its core, Firmus innovates across all layers of the AI Factory, from energy grid management and thermal innovations to GPU and networkingtelemetry and control. This holistic approach creates AI Factories that operate at peak efficiency, delivering high uptime, throughput, and profitability with future-proofed designs.At the heart of this infrastructure is AI FactoryOS, Firmus’ pioneering operating system that integrates data intelligence and control across the physical AI Factory.SMC, Firmus' AI-native cloud platform, leverages SHARP-enabled networking and NCP reference architecture, benefiting from the efficiency of our AI Factory infrastructure. SMC empowers customers to train faster, deploy smarter, and scale globally, while maximizing the value of every token generated.
- Iondrive — Iondrive is an exploration company that provides metals. They offer products that include gold, silver, copper, and other metals. They provide services for industrial use.
A tradition of fostering strong global links in teaching and research and programmes of national significance and international quality.
Show more...Investment focus
- Industry: Health Care, Medical, Therapeutics
- Stage:Pre-Seed, Seed
- Geography: Australia, New Zealand
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Avalia Immunotherapies — Avalia is developing #immunotherapies and #vaccines for the treatment and prevention of infectious diseases and cancer.
Empath Ventures is a venture capital firm that mainly invests in psychedelic medicine companies. The firm specializes in the fields of investment financial services, finance, and venture capital. It was founded in 2021 and headquartered in Los Angeles California.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Personal Health
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 18
- Round size: Seed $1.6M–$12M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Xylo Bio — Psylo is an Australia-based psychedelic biotech business focusing on Psychedelic-inspired medicine to treat mental illness.
- Motif Neurotech — We're building DOT, a miniature brain stimulator designed to restore healthy brain activity in patients with treatment-resistant depression.
- Aperture Therapeutics — Aperture Therapeutics is building an innovative drug discovery platform that embraces the genetic diversity of patients and leverages mechanistic understanding of protective gene variants in the human population.
Investible is an early-stage venture capital firm backing the visionaries advancing humanity through technology in Australia, New Zealand, Southeast Asia and globally.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, United States, Singapore
Investor stats
- Total investments: 249
- Round size: Seed $300k–$5.1M; Pre-Seed $392k–$2M; Series A $1.4M–$20M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Apate.AI — Is the next generation of scam prevention and intelligence. We deploy advanced conversational AI bots combined with real-time insights to protect businesses, governments and communities globally.2
- Inspace XR — Inspire and engage prospective tenants, buyers, and your team with interactive virtual replicas of your assets, with 360 virtual tours, analytics & more.
- GeoSnapShot — Let's put your photos to work. Built for professionals, available to everyone. GeoSnapShot is loved by amateurs, professionals, teams and individuals.
Catalio Capital Management was created by George Petrocheilos and Dr. Jacob Vogelstein to invest in breakthrough biomedical technology companies created or referred by Catalio Capital Management, an elite group of world-renowned, serial scientist-entrepreneurs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, Switzerland
Investor stats
- Total investments: 152
- Round size: Series A $9.7M–$150M; Series B $26M–$130M; Series C $70M–$208M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely actively investing — fresh fund, raised $16M in 2026
Portfolio highlights
- OSPRI — OSPRI is updating the infectious illness testing plan. Established by the combination of Community Direct DX, Scienetix, and the R&D section of Advanta Genetics, OSPRI is among the first molecular testing platforms in the world to be entirely vertically integrated.
- Star Therapeutics — Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.
- BigHat Biosciences — We use machine learning and synthetic biology to design and engineer antibody therapeutics.
We Invest in the Circular Economy, a New Economic Model Focused on a Profitable and Sustainable Future.
Show more...Investment focus
- Industry: Recycling, Manufacturing, Waste Management
- Stage:Seed, Series A, Debt Financing
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 47
- Round size: Seed $2M–$7M; Series A $6M–$16M; Debt Financing $2.6M–$10M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — raised $200M in 2022
Portfolio highlights
- Supersede — Looking for sustainable lightweight waterproof plywood alternative. Upgrade your marine and construction projects with Supersede eco friendly materials.
- TemperPack — Science-driven sustainable packaging for cold chain, food, pharma, pet and more. ClimaCell, Green Cell Foam and WaveKraft platforms. ISTA-certified.
- GreenMantra Technologies — and fuels by recycling plastics utilizes a proprietary thermo-catalytic system and patented process to cost-effectively convert and up-cycle waste plastics, including hard-to-recycle materials such as grocery bags and film, into high-value waxes and other specialty chemicals. These materials have a broad range of applications in the coatings,plastics processing, adhesives, roofing and paving industries.
Time Ventures is an investment fund for Marc Benioff. The company looks to invest in theB2B, hospitality, non-financial services, and commercial products and services sectors.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Sustainability
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Australia
Investor stats
- Total investments: 57
- Round size: Seed $3.1M–$450M; Series A $10M–$80M; Series B $20M–$140M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Revoy — We haul Pacific Northwest freight with our 95% electrified fleet.
- June.ai — Discover June, a digital communication hub that replaces your email experience. June creates a new world for your existing email that gives you more control, interactivity and efficiency.
- June — Transform enterprise system deployment with June. AI-driven implementation for Salesforce, Snowflake, SAP & more. No downtime, faster delivery, full control.
Thistledown Foundation is a private charitable foundation.
Show more...Investment focus
- Industry: Energy, Environmental Engineering, Laser
- Stage:Series A, Venture - Series Unknown, Seed
- Geography: Canada, Germany, Australia
Investor stats
- Total investments: 6
- Round size: Series A $30M–$40M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Avnos — Our HDAC solution offers the broadest geographic potential available, enabling our technology to operate in water-scarce environments.
- Loam Bio — Loam has designed farmer-focused carbon projects that support farmers to build stable soil carbon in cropping and mixed farming systems.
- Marvel Fusion — Marvel Fusion is a developer of fusion energy technology used to offer environment-friendly and safe energy. Its reactor is based on the short pulse, high energy, and electrically efficient laser that is suited for commercializing baseload fusion electrical power helping consumers to access clean, safe, and reliable energy sources.The company wasfounded in 2019 and is headquartered in Munich, Bayern.
Biotechnology VC funding in Australia at a glance
Stats across 451 deals from 376 investors.
Access all 376 VC funds in Australia Biotechnology startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotechnology VC Funds in Australia investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 376 VC funds investing in Australia Biotechnology startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!